Article
Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.
Pediatric blood & cancer - 1 Sept 2011
Kamdar Kala Y, Krull Kevin R, El-Zein Randa A, Brouwers Pim, Potter Brian S, Harris Lynnette L, Holm Suzanne, Dreyer Zoann, Scaglia Fernando, Etzel Carol J, Bondy Melissa, Okcu M Fatih
Abstract excerpt
BACKGROUND: Neurocognitive impairment occurs in 20-40% of childhood acute lymphoblastic leukemia (ALL) survivors, possibly mediated by folate depletion and homocysteine elevation following methotrexate treatment. We evaluated the relationship between folate pathway polymorphisms and neurocognitive impairment after childhood ALL chemotherapy. PROCEDURE: Seventy-two childhood ALL survivors treated with chemotherapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
